COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/617 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227855559393280 |
|---|---|
| author | S. Y. Martsevich N. P. Kutishenko E. V. Shilova A. D. Deev S. A. Shalnova R. G. Oganov I. A. Veliganina E. G. Volkova Yu. E. Voskanjan L. I. Gapon P Ya. Dovgalevskij V. Ya. Ermolina E. M. Idrisova N. N. Ilov A. R. Kiselev S. Yu. Levashov V. A. Nevzorova G. I. Nechaeva T. N. Panova I. I. Reznik V. V. Skibickij L. A. Sokolova V. P. Terentev N. V. Hailo A. V. Shabalin T. V. Shnjukova V. V. Yakusevich |
| author_facet | S. Y. Martsevich N. P. Kutishenko E. V. Shilova A. D. Deev S. A. Shalnova R. G. Oganov I. A. Veliganina E. G. Volkova Yu. E. Voskanjan L. I. Gapon P Ya. Dovgalevskij V. Ya. Ermolina E. M. Idrisova N. N. Ilov A. R. Kiselev S. Yu. Levashov V. A. Nevzorova G. I. Nechaeva T. N. Panova I. I. Reznik V. V. Skibickij L. A. Sokolova V. P. Terentev N. V. Hailo A. V. Shabalin T. V. Shnjukova V. V. Yakusevich |
| author_sort | S. Y. Martsevich |
| collection | DOAJ |
| description | Aim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized groups were comparable on the main clinical characteristics.Results. By the end of the study both systolic and diastolic blood pressure (SBP, DBP) reduced in both groups р<0,0001. There were not differences of antihypertensive effect between investigated drugs (р=0,88 for SBP and р=0,61 for DBP). By the end of the study body mass index decreased by 0,52±0,10 kg/m2 (р<0,0001) in carvedilol group and by 0,26±0,10kg/m2 (р<0,01) in metoprolol group. Carvedilol in comparison with metoprolol had more positive effects on glucose (р<0,01) and lipid blood levels. By the end of the study urine acid blood level reduction was observed in carvedilol group (-16,6 μmol/l) while an increasing tendency - in metoprolol group. Carvedilol did not have negative effect on serum potassium and creatinine levels. Adverse effects rate was 6,3% in carvedilol group and 3,8% - in metoprolol group.Conclusion. The results of open, randomized CAMELLIA trial confirmed antihypertensive effect and good tolerability of carvedilol in common clinical practice as well as demonstrated some its advantages in patients with metabolic syndrome. Carvedilol has positive metabolic effects on lipid, glucose and uric acid levels. Carvedilol therapy is more preferable in patients with arterial hypertension and metabolic risk factors. |
| format | Article |
| id | doaj-art-3c144f61ff3e46aa865e2d37b5c826cd |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-3c144f61ff3e46aa865e2d37b5c826cd2025-08-23T10:00:21ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-0152333810.20996/1819-6446-2009-5-2-33-38616COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIALS. Y. Martsevich0N. P. Kutishenko1E. V. Shilova2A. D. Deev3S. A. Shalnova4R. G. Oganov5I. A. VeliganinaE. G. VolkovaYu. E. VoskanjanL. I. GaponP Ya. DovgalevskijV. Ya. ErmolinaE. M. IdrisovaN. N. IlovA. R. KiselevS. Yu. LevashovV. A. NevzorovaG. I. NechaevaT. N. PanovaI. I. ReznikV. V. SkibickijL. A. SokolovaV. P. TerentevN. V. HailoA. V. ShabalinT. V. ShnjukovaV. V. YakusevichState Research Center for Preventive Medicine of RosmedtechnologyState Research Center for Preventive Medicine of RosmedtechnologyState Research Center for Preventive Medicine of RosmedtechnologyState Research Center for Preventive Medicine of RosmedtechnologyState Research Center for Preventive Medicine of RosmedtechnologyState Research Center for Preventive Medicine of RosmedtechnologyAim. To compare two therapies based on carvedilol or metoprolol in hypertensive patients with overweight and obesity.Material and methods. 320 patients with arterial hypertension (1-2 degree) were involved in the study. 160 patients received carvedilol and 160 patients – metoprolol. Both randomized groups were comparable on the main clinical characteristics.Results. By the end of the study both systolic and diastolic blood pressure (SBP, DBP) reduced in both groups р<0,0001. There were not differences of antihypertensive effect between investigated drugs (р=0,88 for SBP and р=0,61 for DBP). By the end of the study body mass index decreased by 0,52±0,10 kg/m2 (р<0,0001) in carvedilol group and by 0,26±0,10kg/m2 (р<0,01) in metoprolol group. Carvedilol in comparison with metoprolol had more positive effects on glucose (р<0,01) and lipid blood levels. By the end of the study urine acid blood level reduction was observed in carvedilol group (-16,6 μmol/l) while an increasing tendency - in metoprolol group. Carvedilol did not have negative effect on serum potassium and creatinine levels. Adverse effects rate was 6,3% in carvedilol group and 3,8% - in metoprolol group.Conclusion. The results of open, randomized CAMELLIA trial confirmed antihypertensive effect and good tolerability of carvedilol in common clinical practice as well as demonstrated some its advantages in patients with metabolic syndrome. Carvedilol has positive metabolic effects on lipid, glucose and uric acid levels. Carvedilol therapy is more preferable in patients with arterial hypertension and metabolic risk factors.https://www.rpcardio.online/jour/article/view/617arterial hypertensionoverweightobesitybeta-blockerscarvedilolmetoprolol |
| spellingShingle | S. Y. Martsevich N. P. Kutishenko E. V. Shilova A. D. Deev S. A. Shalnova R. G. Oganov I. A. Veliganina E. G. Volkova Yu. E. Voskanjan L. I. Gapon P Ya. Dovgalevskij V. Ya. Ermolina E. M. Idrisova N. N. Ilov A. R. Kiselev S. Yu. Levashov V. A. Nevzorova G. I. Nechaeva T. N. Panova I. I. Reznik V. V. Skibickij L. A. Sokolova V. P. Terentev N. V. Hailo A. V. Shabalin T. V. Shnjukova V. V. Yakusevich COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Рациональная фармакотерапия в кардиологии arterial hypertension overweight obesity beta-blockers carvedilol metoprolol |
| title | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL |
| title_full | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL |
| title_fullStr | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL |
| title_full_unstemmed | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL |
| title_short | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL |
| title_sort | comparison of the metabolic effects of carvedilol and metоprolol in hypertensive patients with overweight and obesity the camellia trial |
| topic | arterial hypertension overweight obesity beta-blockers carvedilol metoprolol |
| url | https://www.rpcardio.online/jour/article/view/617 |
| work_keys_str_mv | AT symartsevich comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT npkutishenko comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT evshilova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT addeev comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT sashalnova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT rgoganov comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT iaveliganina comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT egvolkova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT yuevoskanjan comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT ligapon comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT pyadovgalevskij comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT vyaermolina comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT emidrisova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT nnilov comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT arkiselev comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT syulevashov comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT vanevzorova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT ginechaeva comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT tnpanova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT iireznik comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT vvskibickij comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT lasokolova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT vpterentev comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT nvhailo comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT avshabalin comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT tvshnjukova comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial AT vvyakusevich comparisonofthemetaboliceffectsofcarvedilolandmetoprololinhypertensivepatientswithoverweightandobesitythecamelliatrial |